Current oncology | |
Factors influencing the outcome of stereotactic radiosurgery in patients with five or more brain metastases | |
E. Hamel-Perreault1  | |
[1] Centre hospitalier universitaire de Sherbrooke | |
关键词: Brain metastasis; stereotactic radiosurgery; Gamma Knife; multiple brain metastases; central nervous system; radiation oncology; | |
DOI : 10.3747/co.26.4244 | |
学科分类:肿瘤学 | |
来源: Multimed, Inc. | |
【 摘 要 】
BackgroundStereotactic radiosurgery (srs) for patients with 5 or more brain metastases (bmets) is a matter of debate. We report our results with that approach and the factors influencing outcome. MethodsIn the 103 patients who underwent srs for the treatment of 5 or more bmets, primary histology was nonsmall- cell lung cancer (57% of patients). All patients were grouped by Karnofsky performance status and recursive partitioning analysis (rpa) classification. In our cohort, 72% of patients had uncontrolled extracranial disease, and 28% had stable or responding systemic disease. Previous irradiation for 1–4 bmets had been given to 56 patients (54%). The mean number of treated bmets was 7 (range: 5–19), and the median cumulative bmets volume was 2 cm3 (range: 0.06–28 cm3). ResultsMultivariate analyses showed that stable extracranial disease ( p< 0.001) and rpa ( p= 0.022) were independent prognostic factors for overall survival (os). Moreover, a cumulative treated bmets volume of less than 6 cm3 (adjusted hazard ratio: 2.54;p= 0.006; 95% confidence interval: 1.30 to 4.99) was associated with better os. The total number of bmets had no effect on survival ( p= 0.206). No variable was found to be predictive of local control. The rpa was significant ( p= 0.027) in terms of distant recurrence. ConclusionsOur study suggests that srs is a reasonable option for the management of patients with 5 or more bmets, especially with a cumulative treatment volume of less than 6 cm3.
【 授权许可】
Unknown
【 预 览 】
Files | Size | Format | View |
---|---|---|---|
RO201910255196261ZK.pdf | 300KB | download |